Tue Apr 5, 2022 – 1:58 pm EDTTue Apr 5, 2022 – 2:05 pm EDT
LEEK, England (LifeSiteNews) – The U.K. government has awarded a multimillion pound grant to a chemical manufacturing facility in the English midlands to produce a crucial component for mRNA COVID shots, describing the inoculations as “gene therapies.”
Croda International, a chemicals manufacturer in England, has been granted an eye-watering £15.9 million grant ($20.85 million) “to increase the UK’s capacity to manufacture key vaccine ingredients,” the British government website states.
The public grant will be used by Croda to create lipids, an essential part of the current crop of mRNA-based COVID jabs, to help produce 3 billion doses of the shots from 2023 “as well as other gene therapies,” the government press release reads.
Continuing, the government revealed its intention to invest in mRNA innovations more broadly, funding the application of the technology in flu shots and “gene therapies for cancer and heart disease.”
At the same time, the government announced a £354 million ($465 million) injection for “UK life sciences,” including the Vaccine Taskforce, “to secure innovations and opportunities that have emerged during the pandemic as outlined in the ‘Living with
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors
